Management of Breakthrough Cancer Pain (BTcP)

Agenda:

  • Introduction – Prof Annie Young
  • BTcP: What Is It (and It Isn’t)? – Prof Andrew Davies
  • The Impact of BTcP: Clinical Features – Prof Carla Ripamonti
  • BTcP: The Role of Immediate Release and Rapid Onset Opioids – Dr Philippe Poulain
  • Q&A Period

This Grünenthal Meds webinar is developed in partnership with MASCC and may include discussions about specific medicines.

Course Details

Make sure to login at the top-right to view the video linked below
Management of Breakthrough Cancer Pain (BTcP)
© Copyright 2024 | All Rights Reserved Worldwide  |  Privacy Notice